Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06150547 · ClinicalTrials.gov registry record
A Study of Metabolic Agents Following Brain Radiation
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 5
- Enrollment target
NCT06150547: Completed study, sponsored by Mayo Clinic.
NCT06150547 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06150547 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
This study is being done to determine if CEST magnetic resonance imaging (MRI) and FDG PET are feasible techniques to detect metabolic differences between tumor and brain in patients with a brain tumor.
Interventions
- DIAGNOSTIC_TEST FDG Positron Emission Tomography
- DIAGNOSTIC_TEST Chemical Exchange Saturation Transfer Magnetic Resonance Imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2023-12-27 |
| Est. Completion | 2025-08-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06150547
The ClinicalTrials.gov registry entry for NCT06150547 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FDG Positron Emission Tomography is the first listed.
NCT06150547 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06150547 about?
NCT06150547 is a clinical study titled "A Study of Metabolic Agents Following Brain Radiation". This study is being done to determine if CEST magnetic resonance imaging (MRI) and FDG PET are feasible techniques to detect metabolic differences between tumor and brain in patients with a brain tumor.
What is the current status of trial NCT06150547?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2023-12-27. Estimated completion is 2025-08-04.
What interventions are being tested in trial NCT06150547?
The interventions under investigation include: FDG Positron Emission Tomography (DIAGNOSTIC_TEST), Chemical Exchange Saturation Transfer Magnetic Resonance Imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06150547?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.